Apolipoprotein-E (APOE) genetic testing for Alzheimer’s disease is becoming more important as clinical trials are increasingly targeting individuals carrying APOE-ε4 alleles. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.